These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2165546)

  • 41. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences in corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol before and after weight loss.
    Yanovski JA; Yanovski SZ; Gold PW; Chrousos GP
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1874-8. PubMed ID: 9177399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human corticotropin-releasing hormone (hCRH) test: sex and age differences in plasma ACTH and cortisol responses and their reproducibility in healthy adults.
    Tanaka K; Shimizu N; Imura H; Fukata J; Hibi I; Tanaka T; Nakagawa S; Fujieda K; Takebe K; Yoshinaga K
    Endocr J; 1993 Oct; 40(5):571-9. PubMed ID: 7951523
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats.
    Huang TS
    J Endocrinol Invest; 1997; 20(7):393-6. PubMed ID: 9309537
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Corticotropin releasing factor administered into the ventricular CSF stimulates the pituitary-adrenal axis.
    Rock JP; Oldfield EH; Schulte HM; Gold PW; Kornblith PL; Loriaux L; Chrousos GP
    Brain Res; 1984 Dec; 323(2):365-8. PubMed ID: 6335410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Responses of plasma adrenocorticotropin, cortisol, and dehydroepiandrosterone to ovine corticotropin-releasing hormone in healthy aging men.
    Pavlov EP; Harman SM; Chrousos GP; Loriaux DL; Blackman MR
    J Clin Endocrinol Metab; 1986 Apr; 62(4):767-72. PubMed ID: 3005357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
    Feuillan P; Pang S; Schürmeyer T; Avgerinos PC; Chrousos GP
    J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pituitary-adrenal responsiveness to corticotropin-releasing hormone in patients receiving chronic, alternate day glucocorticoid therapy.
    Schürmeyer TH; Tsokos GC; Avgerinos PC; Balow JE; D'Agata R; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1985 Jul; 61(1):22-7. PubMed ID: 2987294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of various doses of ovine corticotrophin-releasing hormone on plasma and saliva cortisol concentrations in horses.
    Reijerkerk EP; Visser EK; van Reenen CG; van der Kolk JH
    Am J Vet Res; 2009 Mar; 70(3):361-4. PubMed ID: 19254148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adrenocorticotropin responses following administration of ethanol and ovine corticotropin-releasing hormone in the sons of alcoholics and control subjects.
    Waltman C; McCaul ME; Wand GS
    Alcohol Clin Exp Res; 1994 Aug; 18(4):826-30. PubMed ID: 7978091
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma adrenocorticotropin, cortisol, and aldosterone responses to corticotropin-releasing factor: modulatory effect of basal cortisol levels.
    Hermus AR; Pieters GF; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1984 Jan; 58(1):187-91. PubMed ID: 6315759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ovine corticotropin-releasing factor administration in normal men. Pituitary and adrenal responses in the morning and evening.
    Schulte HM; Chrousos GP; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
    Horm Res; 1985; 21(2):69-74. PubMed ID: 2984099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of secondary adrenal insufficiency: findings by corticotropin-releasing hormone test and magnetic resonance imaging in parallel.
    Lin SY; Won JG; Lee TI; Tang KT; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Apr; 65(4):156-63. PubMed ID: 12135194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The short-term infusion of ovine corticotropin-releasing hormone does not alter luteinizing hormone concentrations in young adult men.
    Metzger DL; Kerrigan JR; Rogol AD
    J Clin Endocrinol Metab; 1997 Feb; 82(2):697-700. PubMed ID: 9024279
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence against changes in corticotroph CRF receptors in depressed patients.
    Young EA; Akil H; Haskett RF; Watson SJ
    Biol Psychiatry; 1995 Mar; 37(6):355-63. PubMed ID: 7772643
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pituitary and adrenal responses to pulsatile ovine corticotropin-releasing factor administered to fetal sheep.
    Brooks AN; Challis JR; Norman LJ
    Endocrinology; 1987 Jun; 120(6):2383-8. PubMed ID: 3032589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pituitary response to ovine corticotropin-releasing hormone is enhanced in obese men and correlates with insulin resistance.
    Solano MP; Kumar M; Fernandez B; Jones L; Goldberg RB
    Horm Metab Res; 2001 Jan; 33(1):39-43. PubMed ID: 11280714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dehydration, but not vasopressin infusion, enhances the adrenocortical responses of sheep to corticotropin-releasing hormone or restraint.
    Matthews SG; Parrott RF
    Acta Endocrinol (Copenh); 1991 Nov; 125(5):556-62. PubMed ID: 1759545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing's disease.
    Allolio B; Deuss U; Kaulen D; Leonhardt U; Kallabis D; Hamel E; Winkelmann W
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1427-31. PubMed ID: 3023423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medroxyprogesterone acetate lowers plasma corticotropin and cortisol but does not suppress anterior pituitary responsiveness to human corticotropin releasing factor.
    Lang I; Zielinski CC; Templ H; Spona J; Geyer G
    Cancer; 1990 Nov; 66(9):1949-53. PubMed ID: 2146010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.